Den Europæiske Union -
norsk -
EMA (European Medicines Agency)
xenleta
nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - antibakterielle midler for systemisk bruk, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.
Norge -
norsk -
Statens legemiddelverk
melatonin agb 5 mg
agb-pharma ab - melatonin - tablett - 5 mg
Norge -
norsk -
Statens legemiddelverk
melatonin agb 1 mg
agb-pharma ab - melatonin - tablett - 1 mg
Norge -
norsk -
Statens legemiddelverk
melatonin agb 2 mg
agb-pharma ab - melatonin - tablett - 2 mg
Norge -
norsk -
Statens legemiddelverk
melatonin agb 3 mg
agb-pharma ab - melatonin - tablett - 3 mg
Norge -
norsk -
Statens legemiddelverk
melatonin agb 4 mg
agb-pharma ab - melatonin - tablett - 4 mg
Norge -
norsk -
Statens legemiddelverk
melatonin orifarm 2 mg
orifarm generics a/s - melatonin - tablett, filmdrasjert - 2 mg
Norge -
norsk -
Statens legemiddelverk
melatonin unimedic pharma 1 mg/ ml
unimedic pharma ab - melatonin - mikstur, oppløsning - 1 mg/ ml
Norge -
norsk -
Statens legemiddelverk
melatonin teva 2 mg
teva b.v. - melatonin - depottablett - 2 mg
Den Europæiske Union -
norsk -
EMA (European Medicines Agency)
scemblix
novartis europharm limited - asciminib hydrochloride - leukemi, myelogen, kronisk, bcr-abl positiv - antineoplastiske midler - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.